Boston, MA (August 17, 2017) – Artemis Capital Partners, a Boston-based private equity firm focused on leading industrial technology companies, announced today that is has led the acquisition of StanChem Incorporated, a specialty chemicals manufacturer based in East Berlin, Connecticut.
Founded in 1968, StanChem specializes in the research, development, manufacture, and marketing of emulsion polymers, adhesives, and specialty coatings for a variety of applications including paints, paper and packaging, building products, textiles, and nonwovens. In addition to its specialty polymers business, StanChem produces and markets the well-known Albi line of flame retardant products. Consistent with Artemis’ investment strategy, StanChem possesses a compelling combination of differentiated process and product solutions, a blue-chip customer base, and significant growth potential. According to StanChem’s management team, that growth will be fueled by a new era of innovation and investment.
“Using the ‘Voice of our Customer’ as our guide, we are excited to systematically expand our R&D capabilities to deliver new emulsion polymers to our new and existing customers, applications, and markets,” stated Paul Stenson, PhD, StanChem’s Vice President of Technology, Sales, & Marketing.
Stephen McGuff, StanChem’s Vice President of Operations, concurred: “StanChem’s existing process technology is both formidable and flexible and we plan to further invest in our people, technology, and equipment to realize StanChem’s full potential as a world-class manufacturer in the emulsion polymers industry. After we have implemented our investment plans, we will have significantly increased the Company’s capacity and capabilities.”
In addition to Dr. Stenson and Mr. McGuff, Michael Foley, PhD., Peter Hunter, and James Ward will join StanChem’s Board of Directors on behalf of Artemis, with Dr. Foley serving as the Company’s new Chairman.